Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 3 5Phase 2/3 2Phase 1 2Phase NA 1Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Neoplasm Metastasis 1

Interventions

Oxaliplatin 15Fluorouracil 13Bevacizumab 13Leucovorin 10Capecitabine 8Folfox protocol 7Irinotecan 6IFL protocol 4Cetuximab 4Folic Acid 3Aspirin 3atezolizumab 2XELOX 2Surgical Procedures, Operative 2Magnetic Resonance Spectroscopy 2Drug Therapy 2Chemotherapy, Adjuvant 2trifluridine tipiracil drug combination 1trametinib 1titanium silicide 1sulindac sulfone 1spartalizumab 1sacituzumab govitecan 1regorafenib 1raltitrexed 1pertuzumab 1irinotecan sucrosofate 1folfirinox 1envafolimab 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Colorectal Neoplasms × XELOX × Clear all
NCT03031444 2021-02-01

PARECEC

Peking University Cancer Hospital & Institute

Phase 2/3 Completed
135 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02590367 2015-12-02

Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

Jiangsu Province Hospital of Traditional Chinese Medicine

Phase 2/3 Unknown
64 enrolled
Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡